Systematic review of the clinical efficacy of sibutramine and orlistat in weigth loss, quality of life and its adverse effects in obese adolescents;Revisión sistemática sobre la eficacia clínica de la sibutramina y el orlistat en la pérdida de peso, calidad de vida y sus efectos adversos en obesos adolescentes

Nutricion Hospitalaria

Volumn 26, Issue 3, 2011, Pages 451-457

  Garcia Diaz E ^a   Martin Folgueras T ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Adolescent; Obesity; Orlistat; Quality of life; Sibutamine

Indexed keywords

ANOREXIGENIC AGENT; ANTIOBESITY AGENT; CYCLOBUTANE DERIVATIVE; LACTONE; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ADOLESCENT; DIET; DIET THERAPY; DRUG EFFECT; FEMALE; HUMAN; MALE; META ANALYSIS; OBESITY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; WEIGHT REDUCTION;

ADOLESCENT; ANTI-OBESITY AGENTS; APPETITE DEPRESSANTS; CYCLOBUTANES; DIET; FEMALE; HUMANS; LACTONES; MALE; OBESITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WEIGHT LOSS;

EID: 79957934557     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2011.26.3.5123     Document Type: Review

References (18)

1. Lobstein T, Baur L, Uauy R. IASO International Obesity Task-Force. Obesity in children and young people: a crisis in public health. Obes Rev 2004; 5(Suppl. 1): 4-85.
2. Wang Y, Monteiro CA, Popkin BM. Trends of obesity and underweight in older children and adolescents in United States, Brazil, China and Russia. Am J Clin Nutr 2002; 75: 971-977.
3. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Longterm morbidity and mortality of overweight adolescents: a follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992; 327: 1350-1355.
4. Whitlock EP, O'Connor EA, Williams SB, Beil TL, Lutz KW. Effectiveness of Weight Managent Programs in Children and Adolescents. Evid rep/technol assess 2008; 170: 1-308.
5. Rucker D, Padwal R, Li SK, Curioni C, Lau DC. Long term pharmacotherapy for obesity and overweight: updated metaanalysis. BMJ 2007; 335 (7631): 1194-9.
6. Li Z, Maglione M, Tu W, Mojica W, Arterburn D, Shugarman LR et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med 2005; 142: 532-46.
7. Padwal R, Li SK, Lau DCW. Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev 2003; (4): CD004094.
8. Summerbell CD, Ashton V, Campbell KJ, Edmunds L, Kelly S, Waters E Interventions for treating obesity in children. Cochrane Database Syst Rev 2003: CD001872.
9. McGovern L, Johnson JN, Paulo R, Hettinger A, Singhal V, Kamath C, Erwin PJ, Montori VM. Clinical review: treatment of pediatric obesity: a systematic review and meta-analysis of randomized trials. Journal of Clinical Endocrinology & Metabolism 2008; 93 (12): 4600-5.
10. Berkowitz RI, Wadden TA, Tershakovec AM, et al. Behavior therapy and sibutramine for the treatment of adolescent obesity: A randomized controlled trial. JAMA 2003; 289: 1805-12.
11. Berkowitz RI, Fujioka K, Daniels SR et al. Effects of sibutramine treatment in obese adolescents: A randomized trial. Ann Intern Med 2006; 145: 81-90.
12. Daniels SR, Long B, Crow S et al. Cardiovascular effects of sibutramine in the treatment of obese adolescents: Results of a randomized, double-blind placebo-controlled study. Pediatrics 2007; 120: 147-57.
13. Chanoine JP, Hampl S, Jensen C et al. Effect of orlistat on weight and body composition in obese adolescents: A randomized controlled trial. JAMA 2005; 293: 2873-83.
14. Maahs D, De Serna DG, Kolotkin RL et al. Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents. Endocrine Practice 2006; 12 (1): 18-28.
15. Ozkan B, Bereket A, Turan S, Keskin S. Addition of orlistat to conventional treatment in adolescents with severe obesity. European Journal of Pediatrics 2004; 163 (12): 738-41.
16. García-Morales LM, Berber A, Ias-Lara CC, et al. Use of sibutramine in obese Mexican adolescents: A 6-month, randomized, double-blind, placebo-controlled, parallel-group trial. Clin Ther 2006; 28: 770-82.
17. Godoy-Matos A, Carrazo L, Vieira A et al. Treatment of obese adolescents with sibutramine: a randomized, double-blind controlled study. Journal of Clinical Endocrinology & Metabolism 2005; 90: 1460-65.
18. Van Mil EG, Westerterp KR, Kester AD et al. The effect of sibutramine on energy expenditure and body composition in obese adolescents. Journal of Clinical Endocrinology & Metabolism 2007; 92 (4): 1409-14.